Ys Biopharma Co Stock Z Score
YS Stock  0.85 0.04 4.49% 
YS Biopharma  Z Score 
YS Biopharma Co Company Z Score Analysis
YS Biopharma's ZScore is a simple linear, multifactor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
 
 
 
 

YS Biopharma Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for YS Biopharma is extremely important. It helps to project a fair market value of YS Biopharma Stock properly, considering its historical fundamentals such as Z Score. Since YS Biopharma's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of YS Biopharma's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of YS Biopharma's interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a ZScore, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. ZScores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with ZScores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a socalled 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize zscores proved it to be successful as a predictor of corporate bankruptcy.
Competition 
As per the company's disclosures, YS Biopharma Co has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Transaction History Now
Transaction HistoryView history of all your transactions and understand their impact on performance 
All Next  Launch Module 
YS Biopharma Fundamentals
Return On Equity  0.62  
Return On Asset  0.12  
Profit Margin  (0.67) %  
Operating Margin  (1.17) %  
Current Valuation  374.32 M  
Shares Outstanding  188.33 M  
Shares Owned By Insiders  81.42 %  
Shares Owned By Institutions  4.97 %  
Number Of Shares Shorted  96.84 K  
Price To Book  2.10 X  
Price To Sales  0.29 X  
Revenue  687.2 M  
EBITDA  (76.82 M)  
Net Income  (145.48 M)  
Total Debt  498.63 M  
Book Value Per Share  5.99 X  
Cash Flow From Operations  (182.47 M)  
Short Ratio  0.39 X  
Earnings Per Share  (0.56) X  
Target Price  4.32  
Number Of Employees  754  
Beta  0.55  
Market Capitalization  170.23 M  
Total Asset  1.72 B  
Retained Earnings  (1.87 B)  
Working Capital  377.22 M  
Net Asset  1.72 B 
About YS Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze YS Biopharma Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of YS Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of YS Biopharma Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a marketneutral strategy or pair trading technique involving a short or a long position in a currently trending equity.LTC  Litecoin  
STETH  Staked Ether  
LINK  Chainlink 
Check out YS Biopharma Piotroski F Score and YS Biopharma Valuation analysis. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against riskreturn landscape of the market..
Complementary Tools for YS Biopharma Stock analysis
When running YS Biopharma's price analysis, check to measure YS Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy YS Biopharma is operating at the current time. Most of YS Biopharma's value examination focuses on studying past and present price action to predict the probability of YS Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move YS Biopharma's price. Additionally, you may evaluate how the addition of YS Biopharma to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal  
Idea Analyzer Analyze all characteristics, volatility and riskadjusted return of Macroaxis ideas  
Financial Widgets Easily integrated Macroaxis content with over 30 different plugandplay financial widgets  
Funds Screener Find activelytraded funds from around the world traded on over 30 global exchanges  
Share Portfolio Track or share privately all of your investments from the convenience of any device  
CEOs Directory Screen CEOs from public companies around the world  
Commodity Channel Use Commodity Channel Index to analyze current equity momentum  
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios  
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges  
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and riskadjusted market performance 
Is YS Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of YS Biopharma. If investors know YS Biopharma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about YS Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.56)  Revenue Per Share 5.159  Quarterly Revenue Growth (0.50)  Return On Assets (0.12)  Return On Equity (0.62) 
The market value of YS Biopharma is measured differently than its book value, which is the value of YS Biopharma that is recorded on the company's balance sheet. Investors also form their own opinion of YS Biopharma's value that differs from its market value or its book value, called intrinsic value, which is YS Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because YS Biopharma's market value can be influenced by many factors that don't directly affect YS Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between YS Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if YS Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, YS Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.